title: [The use of cytoflavin for the treatment of chronic brucellosis].
abstract: Clinical and pathogenetic efficacy of cytoflavin as a component of combined therapy of chronic brucellosis was tested in 50 patients who repeated its beneficial effect on the quality of life. The mechanism of cytoflavin action consists of lowering severity of endogenous intoxication and systemic inflammation.
authors.forename: A A
authors.initials: AA
authors.lastname: Shul'diakov
authors.forename: E P
authors.initials: EP
authors.lastname: Liapina
authors.forename: L A
authors.initials: LA
authors.lastname: Soboleva
authors.forename: A A
authors.initials: AA
authors.lastname: Reshetnikov
authors.forename: E V
authors.initials: EV
authors.lastname: Zubareva
authors.forename: A D
authors.initials: AD
authors.lastname: Trubetskov
authors.forename: A V
authors.initials: AV
authors.lastname: Anashchenko
authors.forename: A V
authors.initials: AV
authors.lastname: Evdokimov
mesh_terms: D000328:Adult; D002006:Brucellosis / Q000188:drug therapy*; D002908:Chronic Disease; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D005486:Flavin Mononucleotide / Q000627:therapeutic use*; D006801:Humans; D007290:Inosine Diphosphate / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000627:therapeutic use*; D013386:Succinates / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D004338:Drug Combinations; D013386:Succinates; C507879:cytoflavin; D009536:Niacinamide; D005486:Flavin Mononucleotide; D007290:Inosine Diphosphate